Clinical trials
Prostate clinical trials
Below are recruiting prostate clinical trials, each written for real people, not researchers. We’re tracking 1,360 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05933876Recruiting
Radiation study for limited spread cancer
This trial looks at whether giving radiation treatment to tumors in people with a limited number of metastases can help control the cancer. It is for adults with certain cancer types that have spread to specific organs, and who can manage daily activities with little or no help.
Albacete, AlbaceteAges 18 years+ - NCT07623941Recruiting
Focal Therapy Registry for Localized Prostate Cancer
This registry tracks men with early-stage prostate cancer who choose focal therapy—a targeted treatment that destroys only the cancer area while preserving healthy prostate tissue. The study helps doctors understand how well this approach works and its safety.
New York, New YorkAges 40–85 - NCT07621692RecruitingPhase 1
New radioactive therapy for advanced prostate cancer
This is an early-stage trial testing a new radioactive treatment (161Tb-PSMA) for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. The treatment targets cancer cells using a radioactive metal that may be more effective than older similar treatments.
TaipeiAges 20 years+ - NCT07626151Recruiting
Fluid Management During Robotic Prostate Surgery
This trial compares two approaches to giving IV fluids during robotic prostate removal surgery. Researchers will use a heart-monitoring device to guide one approach and want to see which method works better for patient recovery.
CairoAges 40–80 - NCT06062875RecruitingPhase 2
Testing a drug for enlarged prostate symptoms
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
Glenview, IllinoisAges 45–80 - NCT05393791RecruitingPhase 2
Personalized abiraterone or enzalutamide plan for advanced prostate cancer
This trial compares a personalized (adaptive) treatment plan versus a steady (continuous) plan using either abiraterone or enzalutamide (with the same standard hormone-suppression). It aims to see which approach controls advanced metastatic prostate cancer better while keeping side effects manageable.
Albury, New South WalesAges 18 years+ - NCT07620574Enrolling by invitationPhase 3
Long-Term Study Continuing Cancer Treatment from Previous Trial
This study lets people who were in an earlier Exelixis cancer treatment trial continue receiving the same treatment if it's still helping them. It's designed to see how safe and effective the treatment is over a longer period.
Bay Shore, New YorkAges Any age - NCT07608848RecruitingEarly Phase 1
Imaging study of new cancer-targeting radioactive drugs
This study tests two new radioactive drugs designed to find and image advanced breast or prostate cancer. The drugs use special imaging scans (PET and SPECT) to locate tumors and may help guide future treatment decisions.
Perth, Western AustraliaAges 18 years+ - NCT07607990Recruiting
Rectal Indomethacin to Prevent Catheter Discomfort After Prostate Surgery
This study tests whether a special suppository (indomethacin, a pain-relieving medication) placed in the rectum can reduce bladder catheter discomfort after laparoscopic prostate removal surgery. If it works, it could help patients recover more comfortably.
Hangzhou, ZhejiangAges 18–80 - NCT06236373Recruiting
Understanding cancer survivors' needs in Reggio Emilia
This study aims to understand the challenges and needs of people who have survived certain cancers (breast, prostate, thyroid, colorectal, multiple myeloma, or lymphoma) and their caregivers. It uses interviews or focus groups to gather perspectives.
Reggio Emilia, Reggio EmiliaAges 18 years+ - NCT07576335RecruitingPhase 2
Prehabilitation and rehabilitation for prostate cancer surgery
This study tests a program that combines exercise, nutrition, and mental preparation before and after prostate removal surgery. The goal is to help you recover faster and keep better urinary and sexual function.
Sydney, New South WalesAges 18 years+ - NCT05349227Recruiting
After-cancer digital coaching and wearable tracking outcomes study
This study tests a digital health coaching program (using phone/tablet check-ins and wearable data) to understand health and quality-of-life outcomes after cancer treatment. It may help you learn healthy habits and track progress over time.
Gainesville, FloridaAges 18 years+ - NCT07567521RecruitingPhase 1/Phase 2
TRC003 for Advanced Prostate Cancer That Has Progressed
This early-stage trial tests a new drug called TRC003 for men with advanced prostate cancer that has spread and stopped responding to standard treatments. The drug is designed to target cancer cells that show a specific marker called PSMA.
Taiyuan, ShanxiAges 18 years+ - NCT07568236RecruitingPhase 2
Fezolinetant for hot flushes in men on hormone therapy
This study tests whether fezolinetant can reduce hot flushes in men receiving hormone therapy (ADT) for prostate cancer. If you have bothersome hot flushes, this treatment may help lessen them.
ShatinAges 18 years+ - NCT07567027Recruiting
Testing a spacing gel to improve prostate cancer freezing treatment
This trial tests whether a special gel placed between the prostate and rectum improves the safety and effectiveness of cryoablation—a freezing treatment for prostate cancer. The gel aims to protect the rectum from cold damage during the procedure.
New York, New YorkAges 40–95 - NCT07552922Recruiting
Understanding men's preferences about breast changes from prostate cancer treatment
This study helps doctors understand what men with prostate cancer worry about regarding breast changes from hormone therapy. Your input will help shape future treatment strategies to reduce or prevent these side effects.
Sydney, New South WalesAges 18 years+ - NCT07549256RecruitingPhase 2
Cannabidiol for pain relief in advanced prostate cancer
This trial tests a cannabis-derived medicine called cannabidiol (CBD) for pain relief in men with advanced prostate cancer that has stopped responding to standard treatments. The goal is to see if CBD can help reduce pain when other options have been exhausted.
GistrupAges Any age - NCT06276465RecruitingPhase 3
Darolutamide with or without radiation for advanced prostate cancer
This trial tests whether adding radiation therapy to the drug darolutamide helps men with a specific type of advanced prostate cancer that has stopped responding to hormone therapy and has spread to a few spots seen on special scans. The study aims to find the best way to control the cancer while keeping side effects manageable.
LorientAges 18 years+ - NCT06496581RecruitingPhase 3
Adding a targeted radiation drug for prostate cancer that hasn't responded well to initial treatment
This trial tests if adding a radioactive drug called 177Lu-PSMA-617 to standard therapy helps men whose prostate cancer has spread and hasn't responded well to initial hormone therapy. It's for men whose PSA level is still detectable after 6-8 months of treatment.
AngersAges 18–80 - NCT06640959Recruiting
Bowel health study for prostate cancer radiation
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
Manchester, Greater ManchesterAges 18 years+ - NCT07550517RecruitingPhase 2
Radiation plus experimental nuclear medicine for high-risk prostate cancer
This trial tests whether adding an experimental radioactive drug called PSMA-617 to standard radiation and hormone therapy helps men with high-risk prostate cancer that hasn't spread beyond the pelvis. The radioactive drug targets cancer cells specifically.
Baltimore, MarylandAges 18 years+ - NCT05761366RecruitingPhase 2
18F-PSMA PET/CT scan for PSMA-positive tumors
This Phase 2 study tests an imaging scan called 18F-PSMA PET/CT to find tumors that have a specific marker (PSMA). It may help doctors better locate and evaluate PSMA-positive cancers.
Beijing, ChaoyangAges 18 years+ - NCT07540572RecruitingPhase 1
Testing IDE574 safety and effectiveness in advanced solid tumors
This early-stage trial tests a new drug called IDE574 to see if it is safe and effective in treating advanced cancers that have spread or stopped responding to standard treatments. The trial focuses mainly on hormone-receptor positive breast cancer, but also includes lung, prostate, and colorectal cancers.
Plantation, FloridaAges 18–99 - NCT07538622Recruiting
Registry Study of Zenflow Spring for Urinary Symptoms
This study tracks how well the Zenflow Spring System works for men with urinary symptoms caused by an enlarged prostate. The spring is a small device placed in the urethra (urinary tube) to help improve urinary flow without major surgery.
Phoenix, ArizonaAges 18 years+
Hear when a new Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prostate?
- Yes. Clin2 currently lists 1,360 recruiting prostate studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prostate trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prostate trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.